3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
162
Myelodysplastic Syndromes
46
Leukemia, Myelomonocytic, Chronic
26
Leukemia
16
Myeloproliferative Disorders
11
Recurrence
9
Hematologic Neoplasms
8
Leukemia, Biphenotypic, Acute
7
Primary Myelofibrosis
6
Neoplasms
6
Lymphoma, T-Cell, Peripheral
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Anemia, Refractory, with Excess of Blasts
5
Neoplasm, Residual
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Monocytic, Acute
4
Hematologic Diseases
4
GATA2 Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Interventions
Doxorubicin
7
pembrolizumab
5
Specimen Handling
4
Radiotherapy
4
palbociclib
3
eribulin
3
Radiation
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Biopsy
3
pazopanib
2
brigimadlin
2
abemaciclib
2
Immunoglobulin G
2
zimberelimab
1
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
pemigatinib
1
olaratumab
1
olaparib
1
mirdametinib
1
liposomal doxorubicin
1
lenvatinib
1
enzalutamide
1
durvalumab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
Azacitidine
×
1 year
×
Clear all
No trials found.